Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrae Vandross, MD
NEXT Oncology
Principal Investigator - Angela Alistar, MD
Atlantic Health System
Principal Investigator - Anthony El-Khoueiry, MD
University of Southern California
Principal Investigator - Christina Wu, MD
Mayo Clinic
Principal Investigator - Conor Steuer, MD
Emory University
Principal Investigator - Hani Babiker, MD
Mayo Clinic
Principal Investigator - Jason Henry, MD
Sarah Cannon Research Institute at HealthONE
Principal Investigator - Michael Cecchini, MD
Yale University
Principal Investigator - Zhaohui Jin, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Phoenix, Arizona, United States
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Atlantic Health System
Morristown, New Jersey, United States
- Next Oncology
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2021
- Primary completion
- 25 Apr 2024
- Completion
- 25 Apr 2024
- Last update posted
- 29 Jul 2026
- Registered enrollment
- 50
- Registry id
- NCT05037149
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.